Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WHWK stock hub

Whitehawk Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WHWKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

196.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

WHWK

In the news

Latest news · WHWK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-68.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-45.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WHWK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001422142
Company name	Whitehawk Therapeutics, Inc.
Country	United States
Country code	US
Cusip	00032Q104
Employees	23
Employees Change	-17%
Employees Change Percent	-42.5
Enterprise value	$73.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US00032Q1040
Last refreshed	2026-05-10
Market cap	$196.2M
Market cap category	Micro-Cap
Price	$3.97
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	WHWK
Website	https://ir.whitehawktx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-59.02%
P/B ratio	2.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-91M
Net Income	$-115.8M
Net Income Growth Years	2%
Profit Per Employee	$-5M
ROA	-42.46
Roa5y	-36.15
ROCE	-105.6
ROE	-68.54
Roe5y	-74.23
ROIC	-45.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	143.71%
Cagr3y	-20.99%
EPS Growth Years	4
Revenue Growth	-72.5x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$127.2M
Cash	$123M
Current Assets	$125.5M
Current Liabilities	$11.1M
Equity	$116.2M
Liabilities	$11.1M
Long Term Assets	$1.7M
Long Term Liabilities	$0
Net Cash	$123M
Net Cash By Market Cap	$62.7
Net Cash Growth	-46.75%
Net Debt Equity	$-1.06
Tangible Book Value	$116.2M
Tangible Book Value Per Share	$1.68
WACC	8.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.36
Net Working Capital	$-8.6M
Quick ratio	11.13
Working Capital	$114.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-128.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	143.56%
200-day SMA	2.65
3Y total return	-50.68%
50-day SMA	3.79
50-day SMA vs 200-day SMA	50over200
All Time High	32.99
All Time High Change	-87.97%
All Time High Date	2021-09-23
All Time Low	1.21
All Time Low Change	228.1%
All Time Low Date	2024-08-08
ATR	0.24
Beta	0.71
Beta1y	1.45
Beta2y	0.9
Ch YTD	64.05
High	4
High52	4.48
High52 Date	2026-03-10
High52ch	-11.38%
Low	3.89
Low52	1.55
Low52 Date	2025-05-08
Low52ch	156.13%
Ma50ch	4.83%
Premarket Change Percent	1.27
Premarket Price	$3.99
Premarket Volume	597
Price vs 200-day SMA	49.75%
RSI	51.23
RSI Monthly	51
RSI Weekly	66.05
Sharpe ratio	1.51x
Sortino ratio	2.65
Total Return	-128.91%
Tr YTD	64.05
Tr1m	15.74%
Tr1w	-0.5%
Tr3m	43.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.33
Operating Income	$-122.7M
Price target	$7.5
Price Target Change	$88.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,380,663%
Float Percent	41.23%
Shares Insiders	9.25%
Shares Institutions	23.09%
Shares Out	49,428,177
Shares Qo Q	0.03%
Shares Yo Y	128.91%
Short Float	3.83%
Short Ratio	3.96
Short Shares	1.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	200,641.4x
Bv Per Share	1.68
Ch1m	15.74
Ch1w	-0.5
Ch1y	143.6
Ch3m	43.84
Ch3y	-50.68
Ch6m	91.79
Change	0.76%
Change From Open	2.06
Close	3.94
Days Gap	-1.27
Depreciation Amortization	41,750
Dollar Volume	214,372.1
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-122.7M
EBITDA	$-122.7M
EPS	$-1.67
F Score	0
Fiscal Year End	December
Founded	2,007
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	2.93
Ma150ch	35.45%
Ma20	4.07
Ma20ch	-2.39%
Next Earnings Date	2026-08-06
Open	3.89
Optionable	Yes
Position In Range	72.73
Ppne	2,000
Pre Close	3.94
Price Date	2026-05-08
Ptbv Ratio	1.69
Relative Volume	0.27x
Tr6m	91.79%
Us State	New Jersey
Volume	53,998

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WHWK pay a dividend?

Capital-return profile for this ticker.

Performance

WHWK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WHWK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.1%

Float: +41.2% of shares outstanding

Insider ownership

+9.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

WHWK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.2

Neutral momentum band

Price vs 200-day MA

+49.8%

50/200-day relationship not available

Beta (5Y)

0.71

Less volatile than the market

Sharpe ratio

1.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WHWK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current WHWK stock rating?

Whitehawk Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full WHWK analysis?

The full report lives at /stocks/WHWK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for WHWK?

The latest report frames WHWK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the WHWK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.